
RLMD
USDRelmada Therapeutics Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$2.210
最高
$2.810
最低
$2.190
交易量
0.98M
公司基本面
市值
91.9M
行業
生物科技
國家
United States
交易統計
平均交易量
0.74M
交易所
NCM
貨幣
USD
52週範圍
相關新聞
Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and
Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized
相關股票
WIA
Western Asset Inflation-Linked Income Fund
DUOL
Duolingo Inc.
KRNY
Kearny Financial Corp
HTLD
Heartland Express Inc.
WSBCP
WesBanco Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 6.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
保持更新
設定價格提醒,獲取AI分析更新和即時市場新聞。